140
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial

ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 243-249 | Published online: 12 Nov 2020

References

  • Female Breast Cancer - Cancer Stat Facts. Available from:https://seer.cancer.gov/statfacts/html/breast.html. Accessed 330, 2020.
  • FisherB, AndersonS, BryantJ, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241. doi:10.1056/NEJMoa02215212393820
  • VeronesiU, CascinellN, MarianiL, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232. doi:10.1056/NEJMoa02098912393819
  • MacdonaldS, OncologyR, GeneralM. Breast cancer. Available from:https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf
  • SenkusE, KyriakidesS, OhnoS, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v8–v30. doi:10.1093/annonc/mdv29826314782
  • BartelinkH, MaingonP, PoortmansP, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised Phase 3 trial. Lancet Oncol. 2015;16:47–56. doi:10.1016/S1470-2045(14)71156-825500422
  • BuwengeM, CammelliS, AmmendoliaI, et al. Intensity modulated radiation therapy for breast cancer: current perspectives. Breast Cancer. 2017;9:121–126.28293119
  • FreedmanGM, WhiteJR, ArthurDW, Allen LiX, ViciniFA. Accelerated fractionation with a concurrent boost for early stage breast cancer. Radiother Oncol. 2013;106(1):15–20. doi:10.1016/j.radonc.2012.12.00123333014
  • FrancoP, CanteD, SciaceroP, GirelliG, La PortaMR, RicardiU. Tumor bed boost integration during whole breast radiotherapy: A review of the current evidence. Breast Care. 2015;10:44–49. doi:10.1159/00036984525960725
  • HamiltonDG, BaleR, JonesC, et al. Impact of tumour bed boost integration on acute and late toxicity in patients with breast cancer: A systematic review. Breast. 2016;27:126–135. doi:10.1016/j.breast.2016.03.00227113229
  • MorgantiAG, CillaS, ValentiniV, et al. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol. 2009;90:86–92. doi:10.1016/j.radonc.2008.10.01719010560
  • International Commission on Radiation Units and Measurements. ICRU Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). Bethesda, MD: ICRU; 1999.
  • MorgantiAG, DeodatoF, ZizzariS, et al. Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. Radiother Oncol. 2008;89:320–329. doi:10.1016/j.radonc.2008.07.00918701176
  • DeodatoF, CillaS, MassaccesiM, et al. Daily on-line set-up correction in 3d-conformal radiotherapy: is it feasible?Tumori. 2012;98:441–444. doi:10.1177/03008916120980040723052159
  • CoxJD, StetzJ, PajakTF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346. doi:10.1016/0360-3016(95)00060-C7713792
  • KaplanEL, MeierP. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481. doi:10.1080/01621459.1958.10501452
  • PetoR, PetoJ. Asymptotically efficient rank invariant procedures. J R Stat Soc. 1972;135:185–207.
  • McDonaldMW, GodetteKD, WhitakerDJ, DavisLW, JohnstonePAS. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost. Int J Radiat Oncol Biol Phys. 2010;77:523–530. doi:10.1016/j.ijrobp.2009.05.04219775834
  • Bantema-JoppeEJ, SchilstraC, De BockGH, et al. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months’ follow-up. Int J Radiat Oncol Biol Phys. 2012;83:e471–e477. doi:10.1016/j.ijrobp.2012.01.05022494592
  • CorvòR, RicchettiF, DoinoD, et al. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university. Anticancer Res. 2010;30:4749–4753.21115935
  • TehAYM, WalshL, PurdieTG, et al. Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy - A feasibility and toxicity study. Radiother Oncol. 2012;102:89–95. doi:10.1016/j.radonc.2011.10.01522112781
  • Bantema-JoppeEJ, VredeveldEJ, De BockGH, et al. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; Patterns of recurrence. Radiother Oncol. 2013;108:269–272. doi:10.1016/j.radonc.2013.08.03724055289
  • RazaS, LymberisSC, CiervideR, et al. Comparison of acute and late toxicity of two regimens of 3- and 5-week concomitant boost prone IMRT to standard 6-week breast radiotherapy. Front Oncol. 2012;2:1–10.
  • CanteD, FrancoP, SciaceroP, et al. Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer. Med Oncol. 2013;30:518. doi:10.1007/s12032-013-0518-723460537
  • AlfordSL, PrassasGN, VogelesangCR, LeggettHJ, HamiltonCS. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives. J Med Imaging Radiat Oncol. 2013;57:222–229. doi:10.1111/j.1754-9485.2012.02473.x23551785
  • OsaEOO, DewyngaertK, RosesD, et al. Prone breast intensity modulated radiation therapy: 5-year results. Int J Radiat Oncol Biol Phys. 2014;89:899–906. doi:10.1016/j.ijrobp.2014.03.03624867535
  • ChadhaM, WoodeR, SillanpaaJ, et al. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost. Int J Radiat Oncol Biol Phys. 2013;86:40–44. doi:10.1016/j.ijrobp.2012.11.01023290443
  • FormentiSC, Gidea-AddeoD, GoldbergJD, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25:2236–2242. doi:10.1200/JCO.2006.09.104117470849
  • FreedmanGM, AndersonPR, BleicherRJ, et al. Five-year local control in a Phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;84:888–893. doi:10.1016/j.ijrobp.2012.01.09122580118
  • CanteD, PetrucciE, SciaceroP, et al. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer. Med Oncol. 2017;34:152. doi:10.1007/s12032-017-1020-428776318
  • De RoseF, FogliataA, FranceschiniD, et al. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature. Breast. 2018;42:31–37. doi:10.1016/j.breast.2018.08.09830149235